Neomycin is an antibiotic, which belongs to the same aminoglycoside antibiotic as streptomycin, kanamycin and gentamicin. It is produced by Streptomyces freundii; it is effective against both Gram-positive and Gram-negative bacteria. Neomycin has complete cross-resistance with kanamycin and partial cross-resistance with streptomycin; similar to similar antibiotics, it has nephrotoxicity and inner ear toxicity, and its damage to the inner ear is often irreversible.

This product has a strong bactericidal effect on Gram-negative bacteria and some Gram-positive bacteria. It has an inhibition to Actinomycetes, Leptospira, and Amoeba.
- This product is commonly used in the treatment and control of enteritis, diarrhea, infectious rhinitis, respiratory tract infections caused by Neomycin Sulfate-resistant bacteria (Escherichia coli, Shigella, Staphylococcus aureus, Salmonella, Arizona, Proteus, Bacillus anthracis, Streptococcus, Brucella, Aerogenes).
Pharmacology
This product belongs to the aminoglycoside antibiotics containing 2-deoxystreptamine structure, which can inhibit the biosynthesis of proteins and thus inhibit and kill the bacteria.